+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Travis Perkins Plc (TPK) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 34 Pages
  • July 2026
  • GlobalData
  • Travis Perkins
  • ID: 1291184
Travis Perkins Plc (TPK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Travis Perkins Plc (Travis) is a distributor of building materials and related products to the building, construction, and home improvement markets. The company supplies a wide variety of products such as building materials, interior design materials, ceramic tiles, plumbing, and heating equipment, power tools, kitchen, and joinery products, ventilation and air conditioning, renewable energy systems, and spare parts. It also provides services such as pipeline, plumbing contracts, heating, and mechanical services, repair, and maintenance. It operates a network of retail stores under names, Travis Perkins, Keyline, CCF, BSS, Wickes, Benchmarx, and Toolstation among others across Europe. Travis Perkins is headquartered in Northampton, Northamptonshire, the UK.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • LivaNova Plc - Key Facts
  • LivaNova Plc - Key Employees
  • LivaNova Plc - Key Employee Biographies
  • LivaNova Plc - Major Products and Services
  • LivaNova Plc - History
  • LivaNova Plc - Company Statement
  • LivaNova Plc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • LivaNova Plc - Business Description
  • Business Segment: Cardiopulmonary
  • Overview
  • Performance
  • Business Segment: Neuromodulation
  • Overview
  • Performance
  • Business Segment: Other Revenue
  • Overview
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Rest of World
  • Performance
  • Geographical Segment: United States
  • Performance
  • R&D Overview
  • LivaNova Plc - Corporate Strategy
  • LivaNova Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • LivaNova Plc - Strengths
  • LivaNova Plc - Weaknesses
  • LivaNova Plc - Opportunities
  • LivaNova Plc - Threats
  • LivaNova Plc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • LivaNova Plc, Medical Equipment, Deals By Year, 2020 to YTD 2026
  • LivaNova Plc, Medical Equipment, Deals By Type, 2020 to YTD 2026
  • LivaNova Plc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jun 24, 2026: LivaNova to Host Conference Call on Second-Quarter 2026 Results
  • Jun 05, 2026: LivaNova Appoints Anne Liddy as Chief Legal Officer
  • May 21, 2026: LivaNova Appoints Stefano Folli President of Cardiopulmonary Business Unit
  • May 06, 2026: LivaNova Reports First-Quarter 2026 Results and Raises Full-Year Revenue and Adjusted EPS Guidance
  • Mar 25, 2026: LivaNova to Announce First-Quarter 2026 Results
  • Mar 19, 2026: LivaNova Receives FDA Premarket Approval for aura6000 System to Treat Moderate to Severe Obstructive Sleep Apnea
  • Jan 20, 2026: LivaNova to Release Fourth-Quarter and Full-Year 2025 Results
  • Dec 23, 2025: LivaNova to Present at J.P. Morgan Healthcare Conference in January
  • Dec 02, 2025: LivaNova Appoints Lucile Blaise as Global Head of Commercialization for Obstructive Sleep Apnea
  • Nov 24, 2025: LivaNova's VNS Therapy Procedures Receive Increased Medicare Reimbursement
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • LivaNova Plc, Key Facts
  • LivaNova Plc, Key Employees
  • LivaNova Plc, Key Employee Biographies
  • LivaNova Plc, Major Products and Services
  • LivaNova Plc, History
  • LivaNova Plc, Subsidiaries
  • LivaNova Plc, Key Competitors
  • LivaNova Plc, Ratios based on current share price
  • LivaNova Plc, Annual Ratios
  • LivaNova Plc, Interim Ratios
  • LivaNova Plc, Medical Equipment, Deals By Year, 2020 to YTD 2026
  • LivaNova Plc, Medical Equipment, Deals By Type, 2020 to YTD 2026
  • LivaNova Plc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • LivaNova Plc, Performance Chart (2021 - 2025)
  • LivaNova Plc, Ratio Charts
  • LivaNova Plc, Medical Equipment, Deals By Year, 2020 to YTD 2026
  • LivaNova Plc, Medical Equipment, Deals by Type, 2020 to YTD 2026